Dr. Federica Ferracci is a surgical oncologist and PhD candidate in Oncology Sciences at Università Cattolica del Sacro Cuore – Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome. Her clinical and research focus is on the integrated treatment of peritoneal surface malignancies, with particular expertise in pressurized intraperitoneal aerosol chemotherapy (PIPAC), cytoreductive surgery, and HIPEC. She is currently involved as investigator in prospective clinical trials, including the Nab-PIPAC study for pancreatic cancer with peritoneal metastases, and contributes to the advancement of multimodal strategies in oncologic surgery. She has co-authored numerous peer-reviewed publications in international journals and actively collaborates with global research networks such as CovidSurg, STARSurg, EuroSurg, and the Global Surgery Unit. Dr. Ferracci is a frequent speaker at national and international surgical oncology conferences and serves on the Executive Board of Y-SICO. She is also a member of the Editorial Board of Scientific Reports (Nature Portfolio).